Form 4: Glaukos Director Aimee Weisner Reports Acquisition of Shares and Stock Options Through Compensation Plan

Glaukos Corporation Director Aimee S. Weisner reported the acquisition of common stock and stock options through restricted stock unit grants and compensation policy elections, increasing her beneficial ownership.

Summary

• Aimee S. Weisner, a Director of Glaukos Corp (GKOS), reported changes in her beneficial ownership of company securities.
• On January 2, 2025, Ms. Weisner acquired 461 shares of Common Stock as restricted stock units (RSUs) at a price of $0, received in lieu of annual director retainer fees.
• These 461 RSUs are set to vest in full on the one-year anniversary of the grant date and will be paid in an equivalent number of common shares.
• Following this transaction, Ms. Weisner beneficially owned 17,055 shares, which includes 3,072 unvested or undelivered RSUs, and vested but deferred RSUs.
• On May 29, 2025, Ms. Weisner acquired an additional 2,108 shares of Common Stock as RSUs at a price of $0, pursuant to the Issuer's Director Compensation Policy.
• These 2,108 RSUs will also vest in full on the one-year anniversary of the grant date and are payable in common shares.
• After this transaction, her direct beneficial ownership increased to 19,163 shares, including 4,285 unvested or undelivered RSUs, and vested but deferred RSUs.
• On May 29, 2025, Ms. Weisner also acquired 3,149 stock options (right to buy) with an exercise price of $94.87, granted under the Director Compensation Policy.
• These stock options vest in full on May 29, 2026, and have an expiration date of May 29, 2035.
• Ms. Weisner also holds indirect beneficial ownership of 28,525 shares through the Saeman-Weisner Family Trust and 2,000 shares through the Weisner Saeman Family Irrevocable Trust.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates a director's continued equity accumulation, aligning their interests with shareholders, even though it's part of routine compensation rather than an open market purchase.

Positives

• The acquisition of shares and stock options by a director, even if through compensation, can signal alignment of interests between management and shareholders.
• The grants are part of a structured Director Compensation Policy, indicating a clear framework for rewarding board members.

Risks

• The value of the acquired restricted stock units and stock options is tied to the future performance of Glaukos's common stock, exposing the director to market risk.
• The vesting schedule means the full benefit of these grants is not immediate and depends on continued service and company performance.

Future Outlook

This Form 4 filing primarily details past and future vesting of equity compensation for a director and does not provide forward-looking statements regarding the company's financial performance or strategic outlook.

Industry Context

This filing is a routine insider transaction report specific to Glaukos Corporation and its director compensation practices. It does not provide broader insights into industry trends or competitive dynamics within the ophthalmic medical device sector.

Corporate Governance

Related Party Transactions

• Aimee S. Weisner holds indirect beneficial ownership of 28,525 shares through the Saeman-Weisner Family Trust and 2,000 shares through the Weisner Saeman Family Irrevocable Trust, indicating related party ownership structures.

Stakeholder Impact

• Shareholders: The director's increased equity stake, even through compensation, may be viewed positively as it aligns her financial interests with those of other shareholders.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The 461 restricted stock units granted on January 2, 2025, will vest on their one-year anniversary.
• The 2,108 restricted stock units granted on May 29, 2025, will vest on their one-year anniversary.
• The 3,149 stock options granted on May 29, 2025, will vest on May 29, 2026.

Key Dates

Keywords

Glaukos, GKOS, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, Stock Options, Beneficial Ownership, Equity Compensation